Prepare point wise notes for post graduate university theory exam. Question: Bone Morphogenetics Proteins in Periodontics, using uploaded references only.
"Bone Morphogenetic" in ~/attachments/6b9d4081-5370-4626-ad54-fdc569b164cc
"BMP" in ~/attachments/6b9d4081-5370-4626-ad54-fdc569b164cc
"Bone Morphogenetic" in .../6b9d4081-5370-4626-ad54-fdc569b164cc/Carranza's Clinical Periodontology, 10th Edition - Copy.txt
"Bone Morphogenetic" in .../6b9d4081-5370-4626-ad54-fdc569b164cc/Clinical Periodontology and Implant Dentistry 6th Edition - Copy.txt
"BMP" in .../6b9d4081-5370-4626-ad54-fdc569b164cc/Carranza's Clinical Periodontology, 10th Edition - Copy.txt
"BMP" in .../6b9d4081-5370-4626-ad54-fdc569b164cc/Clinical Periodontology and Implant Dentistry 6th Edition - Copy.txt
"BMP" in .../6b9d4081-5370-4626-ad54-fdc569b164cc/Orban's Oral Histology & Embryology.txt
- Newman & Carranza 14th ed. - Most comprehensive: BMP classification, molecular mechanisms (Runx2-Smad, RUNX2/OSX/DLX5/OSE2), clinical applications in intrabony/furcation/fenestration/supra-alveolar defects, INFUSE FDA approval, BMP-7 in patterned scaffolds, adverse effects, tissue engineering framework.
- Carranza 10th ed. - BMP-3/osteogenin identification, DFDBA-BMP relationship, rhBMP-2 in critical-sized defects with barrier membranes, donor age effect on BMP content.
- Lindhe 6th ed. - Receptor-Smad signal transduction details, BMP-2 clinical trial (Fiorellini 2005 buccal wall defect model), BMP-7 (OP-1) in implants and sinus augmentation, gene therapy (adenoviral BMP-7), growth factor delivery challenges.
- Orban's Oral Histology - Role of BMPs (2, 3, 4, 7) in cementoblast differentiation, BMP-3 in root-lining cells, BMP delivery from absorbable collagen sponge for bone defect healing, intramembranous ossification via BMPs and cbfa1.
- Periodontics Medicine Surgery Implants - Quantitative data on rhBMP-2 in horizontal defects (3.5 mm bone, 1.6 mm cementum gain), ankylosis concern, BMP-7 advantage over BMP-2, osteoinductive mechanism (ectopic bone formation), gene therapy rationale for overcoming short BMP half-life.